Details for 2018825837
Up to date per 01.04.2026
Actions
Details for 2018825837
Granted/Registered
European Patent
07.10.2020 A
10.08.2022 B1
30.11.2017
US
201762593033 P
17.03.2018
US
201862644425 P
22.10.2018
US
201862748782 P
A61K 38/17 20060101AFI20190607BHEP
Owner
Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591US
Representative
Representative
Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT
Inventor
VITTI, Robert L.c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown New York 10591US
BERLINER, Alyson J.c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown New York 10591US
CHU, Karenc/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown New York 10591US
Information about Fees